Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2415-2417

  Scoffone, Viola C ^a   Spadaro, Francesca ^a   Udine, Claudia ^a   Makarov, Vadim ^b   Fondi, Marco ^c   Fani, Renato ^c   De Rossi, Edda ^a   Riccardi, Giovanna ^a   Buroni, Silvia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 OXIDO 5 (TRIFLUOROMETHYL)PYRIDIN 2 YL THIOCYANATE; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; PYRIDINE DERIVATIVE; SPARFLOXACIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BURKHOLDERIA CENOCEPACIA; CELL DIVISION; EFFUSION; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BURKHOLDERIA CENOCEPACIA; DRUG RESISTANCE, BACTERIAL; PYRIDINES;

EID: 84896925194     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02438-13     Document Type: Article

References (13)

1. LiPuma JJ. 2010. The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 23:299-323. http://dx.doi.org/10.1128/CMR.00068-09.
2. Jones AM, Dodd ME, Govan JRW, Barcus V, Doherty CJ, Morris J, Webb AK. 2004. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 59:948-951. http://dx.doi.org/10.1136/thx. 2003.017210. (Pubitemid 39490778)
3. Gibson RL, Burns JL, Ramsey BW. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951. http://dx.doi.org/10.1164/rccm.200304-505SO. (Pubitemid 37267172)
4. Waters V. 2012. New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Curr. Pharm. Des. 18:696-725. http://dx.doi.org/10.2174/ 138161212799315939.
5. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. 2000. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am. J. Respir. Crit. Care Med. 161:1206-1212. http://dx.doi.org/10.1164/ajrccm.161.4.9907147. (Pubitemid 30243831)
6. Lomovskaya O, Lee A, Hoshino K, Ishida H, Mistry A, Warren MS, Boyer E, Chamberland S, Lee VJ. 1999. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43:1340-1346. (Pubitemid 29259322)
7. Chan YY, Tan TM, Ong YM, Chua KL. 2004. BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 48:1128-1135. http://dx.doi.org/10.1128/AAC.48.4.1128-1135.2004. (Pubitemid 38405465)
8. Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, Venturi V, Valvano MA, Riccardi G. 2009. Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol. 9:200. http://dx.doi.org/10.1186/1471- 2180-9-200.
9. Bazzini S, Udine C, Sass A, Pasca MR, Longo F, Emiliani G, Fondi M, Perrin E, Decorosi F, Viti C, Giovannetti L, Leoni L, Fani R, Riccardi G, Mahenthiralingam E, Buroni S. 2011. Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One 6:e18902. http://dx.doi.org/10.1371/journal.pone.0018902.
10. Salina E, Ryabova O, Kaprelyants A, Makarov V. 2013. New 2-thiopyridines as potential candidates for killing both actively growing and dormant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 58:55-60. http://dx.doi.org/10.1128/AAC.01308-13.
11. Nikaido H, Pagès JM. 2012. Broad specificity efflux pumps and their role in multidrug resistance of Gram negative bacteria. FEMS Microbiol. Rev. 36:340-363. http://dx.doi.org/10.1111/j.1574-6976.2011.00290.x.
12. Studier FW. 2005. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41:207-234. http://dx.doi.org/10.1016/j. pep.2005.01.016.
13. Craig FF, Coote JG, Parton R, Freer JH, Gilmour NJ. 1989. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J. Gen. Microbiol. 135:2885-2890. (Pubitemid 19286730)